Bedridden Thromboprophylaxis: Dosing
Approximately 75% of venous thromboembolism (VTE) cases occur among acutely ill non-surgical patients1
For prophylaxis of proximal deep vein thrombosis (DVT) in patients bedridden due to a medical condition, including, but not limited to:2
- Congestive cardiac failure (NYHA class III or IV)
- Acute respiratory failure
- Acute infection
- Patients who also have a predisposing risk factor for VTE, such as age over 75 years, obesity, cancer or previous history of VTE.
Fragmin® 5,000 IU s.c. o.d. for up to 14 days2
1. Leizorovicz A et al. Circulation 2004;110:874–879.
2. Fragmin SmPC [Medical Thromboprophylaxis (5,000 IU syringes)]. Available at: https://www.medicines.org.uk/emc/product/4247
*Including, but not limited to: congestive cardiac failure (NYHA class III or IV), acute respiratory failure or acute infection, who also have a predisposing risk factor for VTE such as age over 75 years, obesity, cancer or previous history of VTE.~
†In patients with chronic renal insufficiency or acute renal failure.
PP-FRA-GBR-0154. June 2019